loader
Please Wait
Applying Filters...

Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Approved Drug Products containing 209360 listed in the FDA Orange Book. Original Data : FDA Website

    Client Virtual Booth
    Menu

    La Jolla Pharmaceutical

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    PharmaCompass

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 LA JOLLA PHARMA (3)

    filter

    01 SOLUTION;INTRAVENOUS (3)

    filter

    01 DISCN (1)

    02 RX (2)

    filter

    01 GIAPREZA (3)

    filter

    01 Yes (3)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us
    Contact Supplier
      Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
      Post an Enquiry Post an Enquiry
      Flag U.S.A
      Virtual Booth Virtual Booth
      Digital Content Digital Content

      ANGIOTENSIN II ACETATE

      PDF Supplier PDF
      URL Supplier Web Content
      SOLUTION; INTRAVEN...
      EQ 0.5MG BASE/ML (...
      2021-12-23
      209360
      GIAPREZA
      RX
      Yes
      ASK
      US
      PHARMACOMPASS
      Upload
      your Marketing & Sales content
      Contact Supplier
        Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
        Post an Enquiry Post an Enquiry
        Flag U.S.A
        Virtual Booth Virtual Booth
        Digital Content Digital Content

        ANGIOTENSIN II ACETATE

        PDF Supplier PDF
        URL Supplier Web Content
        SOLUTION; INTRAVEN...
        EQ 2.5MG BASE/ML (...
        2017-12-21
        209360
        GIAPREZA
        RX
        Yes
        ASK
        US
        PHARMACOMPASS
        Upload
        your Marketing & Sales content
        Contact Supplier
          Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
          Post an Enquiry Post an Enquiry
          Flag U.S.A
          Virtual Booth Virtual Booth
          Digital Content Digital Content

          ANGIOTENSIN II ACETATE

          PDF Supplier PDF
          URL Supplier Web Content
          SOLUTION; INTRAVEN...
          EQ 5MG BASE/2ML (E...
          2017-12-21
          209360
          GIAPREZA
          DISCN
          Yes
          ASK
          US
          PHARMACOMPASS
          Upload
          your Marketing & Sales content

          Looking for FDA Orange Book APPLICATION 209360

          Looking for FDA Orange Book APPLICATION 209360 3

          19

          La Jolla Pharmaceutical, based in U.S.A, is a pharmaceutical company.

          One of their notable products is ANGIOTENSIN II ACETATE, with a corresponding application number 209360.

          Regulatory Information RX

          With a dosage strength EQ 0.5MG BASE/ML (EQ 0.5MG BASE/ML)

          Dosage Form Route SOLUTION; INTRAVENOUS

          Reference Listed Drug Yes

          Approved since 2021-12-23

          18

          La Jolla Pharmaceutical, based in U.S.A, is a pharmaceutical company.

          One of their notable products is ANGIOTENSIN II ACETATE, with a corresponding application number 209360.

          Regulatory Information RX

          With a dosage strength EQ 2.5MG BASE/ML (EQ 2.5MG BASE/ML)

          Dosage Form Route SOLUTION; INTRAVENOUS

          Reference Listed Drug Yes

          Approved since 2017-12-21

          17

          La Jolla Pharmaceutical, based in U.S.A, is a pharmaceutical company.

          One of their notable products is ANGIOTENSIN II ACETATE, with a corresponding application number 209360.

          Regulatory Information DISCN

          With a dosage strength EQ 5MG BASE/2ML (EQ 2.5MG BASE/ML)

          Dosage Form Route SOLUTION; INTRAVENOUS

          Reference Listed Drug Yes

          Approved since 2017-12-21

          Post Enquiry
          POST ENQUIRY